Welcome to LookChem.com Sign In|Join Free
  • or
1,1-dimethylethyl 4-({ [(1S,2R)-2-phenylcyclopropyl]amino}methyl)-1-piperidinecarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1401966-32-2

Post Buying Request

1401966-32-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1401966-32-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1401966-32-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,1,9,6 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1401966-32:
(9*1)+(8*4)+(7*0)+(6*1)+(5*9)+(4*6)+(3*6)+(2*3)+(1*2)=142
142 % 10 = 2
So 1401966-32-2 is a valid CAS Registry Number.

1401966-32-2Downstream Products

1401966-32-2Relevant academic research and scientific papers

Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor

Wang, Xiaowen,Su, Mingbo,Li, You,Liu, Tongchao,Wang, Yujie,Chen, Yabing,Tang, Le,He, Yu-Peng,Ding, Xiaoguang,Yu, Fang,Shen, Jingkang,Li, Jia,Zhou, Yubo,Chen, Yue-Lei,Xiong, Bing

, p. 844 - 847 (2019)

Tranylcypromine moiety extracted from LSD1 inhibitors and 6-trifluoroethyl thienopyrimidine moiety from menin-MLL1 PPI inhibitors were merged to give new chemotypes for medicinal chemistry study. Among 15 new compounds prepared in this work, some exhibited nanomolar LSD1 activity and good selectivity over MAO-A/B, low micromolar menin-MLL1 PPI inhibitory activity, as well as submicromolar MV4-11 antiprofilative activities. Intracellular LSD1 engagement of compounds with higher enzymatic and antiproliferative activities was confirmed by CD86 mRNA up-regulation experiments.

Cyclopropylamines as LSD1 inhibitors

-

Page/Page column 39; 40; 41, (2016/06/14)

This invention relates to the use of cyclopropylamine derivatives for the modulation, notably the inhibition of the activity of Lysine-specific demethylase 1 (LSD1). Suitably, the present invention relates to the use of cyclopropylamines in the treatment of cancer.

LSD1 Fluorocyclopropylamine as inhibitor

-

Paragraph 0165, (2016/10/09)

This invention relates to the use of cyclopropylamine derivatives for the modulation, notably the inhibition of the activity of Lysine-specific demethylase 1 (LSD1). Suitably, the present invention relates to the use of cyclopropylamines in the treatment of cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1401966-32-2